Kalaris Therapeutics (KLRS) Stock Insights

KLRS price $1.96 +0.10 +5.17%

Ticker
KLRS
Price
$1.96
Change
+0.10 +5.17%
Market cap ?
$42.72M
Beta ?
0.21
Sector
Healthcare
Industry
Biotechnology

Fair value

KLRS fair value Not meaningful. Price $1.96.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare KLRS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.52——
2026-08-11-0.48-0.49——
2026-05-12-0.46-0.52——
2026-03-17-0.44-0.56——
2025-11-12-0.64-0.66——
2025-08-13-0.61-0.51——
2025-05-14-2.52-0.78——
2025-03-07-3.64-2.76——
2024-11-12-0.04-0.14——
2024-06-30-1.13-2.37——
2024-05-13-5.98-3.62——
2023-12-31-0.70-9.84——
2023-09-30-8.94———
2023-06-30-11.00———
2023-03-31-10.15———
2022-12-31-9.42———
2022-09-30-11.39———
2022-06-30-15.93———
2022-03-31-15.76———
2021-12-31-20.96———
2021-09-30-16.62———
2021-06-30-13.87———
2021-03-31-11.44———
2020-12-31-9.36———
2020-09-30-13.42———
2020-06-30-4.11———
2020-03-31-3.30———
2019-12-31-3.09———
2019-09-30-2.57———
2019-06-30-1.87———
2019-03-31-0.89—165.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-27Vandekop Amy O'LearyBuy10.00K$4.1041.00K
2026-08-01KEATING LAURIEBuy18.00K$3.5163.18K
2026-08-01KEATING LAURIEOther0——
2026-07-27Vandekop Amy O'LearyOther0——
2026-07-27Vandekop Amy O'LearyOther27.41K$7.31200.40K
2026-07-27Vandekop Amy O'LearyOther20.00K$6.81136.20K
2026-07-20Bayko Liisa AnnBuy220.00K$4.00880.00K
2026-07-20Bayko Liisa AnnOther0——
2026-06-03Jovan-Embiricos MoranaBuy9.00K$4.7242.48K
2026-06-03Ferrara NapoleoneBuy9.00K$4.7242.48K
2026-06-03Hallal DavidBuy9.00K$4.7242.48K
2026-06-03AKKARAJU SRINIVASBuy9.00K$4.7242.48K
2026-06-03Dybbs MichaelBuy9.00K$4.7242.48K
2026-06-03ADAMIS ANTHONY PBuy9.00K$4.7242.48K
2026-06-03PATTERSON LEONE DBuy9.00K$4.7242.48K
2026-05-20AKKARAJU SRINIVASSell66.91K——
2026-05-20AKKARAJU SRINIVASBuy244.30K$4.831.18M
2026-05-20AKKARAJU SRINIVASBuy4.47K——
2026-05-20AKKARAJU SRINIVASBuy14.94K——
2026-03-20Hagen Brett RSell1.92K$6.7212.87K
2026-03-19Hagen Brett RBuy60.80K$6.81414.05K
2026-03-19Oxtoby AndrewBuy222.00K$6.811.51M
2026-03-19Gall MatthewBuy95.00K$6.81646.95K
2026-03-19Feinsod MatthewBuy135.00K$6.81919.35K
2025-12-22AKKARAJU SRINIVASBuy1.50M$10.0015.00M
2025-12-18AKKARAJU SRINIVASBuy479.85K$10.425.00M
2025-11-03Gall MatthewBuy235.00K$4.991.17M
2025-11-03Gall MatthewOther0——
2025-04-10Hagen Brett RBuy50.26K$7.31367.42K
2025-04-10AKKARAJU SRINIVASBuy18.00K$7.31131.58K
2025-04-10Jovan-Embiricos MoranaBuy18.00K$7.31131.58K
2025-04-10PATEL SAMIR CHANDRAKANTBuy18.00K$7.31131.58K
2025-04-10Ferrara NapoleoneBuy18.00K$7.31131.58K
2025-04-10Oxtoby AndrewBuy287.00K$7.312.10M
2025-04-10ADAMIS ANTHONY PBuy18.00K$7.31131.58K
2025-04-10Feinsod MatthewBuy101.00K$7.31738.31K
2025-04-10Feinsod MatthewBuy70.55K$7.31515.73K
2025-04-10PATTERSON LEONE DBuy18.00K$7.31131.58K
2025-04-03PATTERSON LEONE DOther0——
2025-03-26Hagen Brett RSell907$8.978.14K
2025-03-18AKKARAJU SRINIVASOther0——
2025-03-18Samsara BioCapital GP, LLCOther0——
2025-03-18Ferrara NapoleoneBuy504.00K——
2025-03-18PATEL SAMIR CHANDRAKANTBuy252.00K——
2025-03-18PATEL SAMIR CHANDRAKANTBuy105.91K$0.8590.03K
2025-03-18PATEL SAMIR CHANDRAKANTBuy100.80K——
2025-03-18Feinsod MatthewBuy28.22K$0.8523.99K
2025-03-18Feinsod MatthewBuy4.03K——
2025-03-18Oxtoby AndrewBuy476.61K$0.85405.12K
2025-03-18AKKARAJU SRINIVASBuy11.44M——
2025-03-18ADAMIS ANTHONY PBuy19.48K$0.5510.72K
2025-03-18ADAMIS ANTHONY PBuy12.99K$0.557.14K
2025-03-18AKKARAJU SRINIVASOther0——
2025-03-18Ferrara NapoleoneOther0——
2025-03-18Dybbs MichaelOther0——
2025-03-18PATEL SAMIR CHANDRAKANTOther0——
2025-03-18Oxtoby AndrewOther0——
2025-03-18Feinsod MatthewOther0——
2025-03-18ADAMIS ANTHONY POther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 56, holders -2 vs prior quarter. Ownership 75.79%.

HolderSharesChangeChange %Value
SAMSARA BIOCAPITAL, LLC12.88M-66.91K-0.52%52.43M
RTW INVESTMENTS, LP1.30M00.00%5.29M
ALYESKA INVESTMENT GROUP, L.P.572.69K00.00%2.33M
SIREN, L.L.C.435.80K00.00%1.77M
VANGUARD CAPITAL MANAGEMENT LLC398.71K143.36K+56.14%1.62M
IKARIAN CAPITAL, LLC360.00K00.00%1.47M
UBS GROUP AG262.13K255.95K+4138.86%1.07M
RENAISSANCE TECHNOLOGIES LLC149.35K83.20K+125.77%607.86K
MARSHALL WACE, LLP139.20K71.32K+105.07%566.55K
GEODE CAPITAL MANAGEMENT, LLC114.04K26.49K+30.26%464.29K
ADAR1 CAPITAL MANAGEMENT, LLC100.00K00.00%407.00K
WOODLINE PARTNERS LP100.00K00.00%407.00K
WHI TRUST CO LLC97.49K00.00%396.80K
RAYMOND JAMES FINANCIAL INC97.16K-21.72K-18.27%395.46K
CITADEL ADVISORS LLC95.77K95.77KNew389.79K
BOOTHBAY FUND MANAGEMENT, LLC92.26K00.00%375.50K
VERDAD ADVISERS, LP80.30K80.30KNew326.81K
MORGAN STANLEY72.33K33.98K+88.62%294.37K
VANGUARD FIDUCIARY TRUST CO66.18K29.46K+80.24%269.35K
BLACKROCK, INC.54.44K18.40K+51.05%221.58K
BELPOINTE ASSET MANAGEMENT LLC40.00K00.00%162.80K
FORTIS CAPITAL ADVISORS, LLC40.00K00.00%162.80K
PALE FIRE CAPITAL SE39.63K39.63KNew161.28K
SQUAREPOINT OPS LLC38.77K-998-2.51%157.81K
BRIDGEWAY CAPITAL MANAGEMENT, LLC32.50K10.00K+44.44%132.28K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Kalaris Therapeutics (KLRS) Stock Insights

KLRS$1.96+0.10 +5.17%

$42.72M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History